Neuropathix, Inc. Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019
Accesswire
*Published Preclinical Data Shows KLS-13019 More Effective Than Cannabidiol (CBD) in Prevention, Reversal of Chemotherapy-Induced..
Temple University School of Medicine
News and Video Search Results
News coverage
-
Alector Announces Appointment of Gary Romano, M.D., Ph.D., as Chief Medical Officer
GlobeNewswire
-
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
GlobeNewswire
-
Eyenuk Announces Publication of Strong EyeArt® Pivotal Clinical Trial Results in JAMA Network Open
GlobeNewswire
-
CHRISTUS Health announces new affiliation with Texas A&M
GlobeNewswire
0 shares
1 views
You might like
Temple University School of Medicine media coverage
Neuropathix, Inc. Wholly Owned Subsidiary Kannalife Sciences, Inc. Awarded $2.97 Million Phase 2 Study Grant from National Institute of Neurological Disorders and Stroke (NINDS)
Accesswire
*Pharmaceutical Assets Include Company's Non-Opioid Anti-inflammatory Compound KLS-13019 to Treat Chemotherapy Induced Peripheral..
Can Biden Heal America’s Deep Wounds? – Analysis
Eurasia Review
Advertisement
More coverage
HIV-Like Virus Eliminated from the Genomes of Primates; Excision BioTherapeutics Advancing the Innovation to Clinical Development
GlobeNewswire
Study published in Nature Communications marks a critical step toward the development of a possible cure for human HIV..
-
Corvus Completes Enrollment in Phase 1 Study of CPI-006 for Patients with COVID-19 and Presents Study Data at 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
GlobeNewswire
-
CRISPR-Focused Excision BioTherapeutics Announces Business Advisory Board and Addition of Interim Chief Business Officer
GlobeNewswire
-
Outlook on the Proteome Profiling Services Worldwide Market to 2030 - Featuring Creative Biolabs, Creative Proteomics & Poochon Scientific Among Others
GlobeNewswire
-
War surgeon saved lives under pressure
CBS News